Table 2 The clinical characteristics of the blood culture positive patients for Stenotrophomonas maltophilia
n (%) | ||
|---|---|---|
Age Children (≤ 18 years) Adult (> 18 years) (median year, average range) | 16 (30.7%) 36 (69.2%) 39 (1 months − 87 years) | |
Gender (Female) | 30 (57%) | |
ICU | 32 (61.5%) | |
Baseline diseases | ||
Hypertension Malignancy Leukemia Diabetes mellitus Hearth diseases Chronic renal failure Acute renal failure Liver disease COVID 19 Pulmonary disease Sepsis Acute gastroenteritis Intracranial abscess | 9 (17%) 9 (17%) 3 (5.7%) 8 (15.3%) 13 (25%) 9 (17%) 2 (3.8%) 1 (1.9%) 10 (19.2%) 10 (19.2%) 2 (3.8%) 1 (1.9%) 1 (1.9%) | |
Catheter | 46 ( 88.4%) | |
Central venous catheter | 43 (83% ) | |
Previous antibiotic usage | 40 (76.9%) | |
Cephalosporins Carbapenem Piperacillin-tazobactam Sulbactam-ampisilin Aminoglycosides Glycopeptides | 6 (11.5%) 30 (57.6%) 5 (9.6%) 2 (3.8%) 2 (3.8%) 16 (30.7%) | |
Bronchoscopy | 5 (9.6%) | |
Total parenteral nutrition | 10 (19.2%) | |
Operation | 21 (40.38%) | |
Interventional radiology | 2 (3.8%) | |